These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11944022)

  • 1. Lipoprotein (a): where does the atherogenicity reside?
    Berglund L
    J Lab Clin Med; 2002 Mar; 139(3):131-2. PubMed ID: 11944022
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein(a)-lowering therapies: a double edged sword?
    Lippi G
    Atherosclerosis; 2015 Oct; 242(2):504-5. PubMed ID: 26298742
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic basis for multimodal relationship between apolipoprotein (a) size and lipoprotein (a) concentration in Mexican-Americans.
    Rainwater DL
    Atherosclerosis; 1995 Jun; 115(2):165-71. PubMed ID: 7661875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) plasma levels and apo(a) isoforms are not associated with longevity or disability in a sample of Italian octo-nonagenarians. Associazione Medica Sabin.
    Zuliani G; Bader G; Imbastaro T; Mezzetti A; Taddeo U; Kostner GM; Fellin R
    Aging (Milano); 1995 Oct; 7(5):385-91. PubMed ID: 8719606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lp(a) concentrations are related to plasma lipid concentrations.
    Rainwater DL
    Atherosclerosis; 1996 Nov; 127(1):13-8. PubMed ID: 9006799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) concentration and apolipoprotein(a) size: A synergistic role in advanced atherosclerosis?
    Marcovina SM; Koschinsky ML
    Circulation; 1999 Sep; 100(11):1151-3. PubMed ID: 10484533
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular genetics of lipoprotein (a): new pieces to the puzzle.
    Gaw A; Hobbs HH
    Curr Opin Lipidol; 1994 Apr; 5(2):149-55. PubMed ID: 8044418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein(a) and atherosclerosis.
    Ishibashi S
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):1-2. PubMed ID: 11145926
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lipoprotein(a) and the cardiovascular risk during estrogen-progestin replacement therapy in postmenopause].
    Porcelli A; Calleri L; Gallello D; Taccani C; Surico N
    Minerva Ginecol; 1997; 49(1-2):39-42. PubMed ID: 9162884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension.
    Sechi LA; Kronenberg F; De Carli S; Falleti E; Zingaro L; Catena C; Utermann G; Bartoli E
    JAMA; 1997 Jun; 277(21):1689-95. PubMed ID: 9169895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a): Looking ahead.
    Scanu AM
    Nutr Metab Cardiovasc Dis; 2005 Oct; 15(5):331-3. PubMed ID: 16216717
    [No Abstract]   [Full Text] [Related]  

  • 12. A single point mutation (Trp72-->Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a).
    Scanu AM; Pfaffinger D; Lee JC; Hinman J
    Biochim Biophys Acta; 1994 Oct; 1227(1-2):41-5. PubMed ID: 7918682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lp(a) lipoprotein, vascular disease, and mortality in the elderly.
    Kovesdy CP
    N Engl J Med; 2004 Mar; 350(11):1150-2; author reply 1150-2. PubMed ID: 15017680
    [No Abstract]   [Full Text] [Related]  

  • 14. Decrease of Lp(a) during weight reduction in obese children is modified by the apo(a) kringle-IV copy number variation.
    Brandstätter A; Lingenhel A; Zwiauer K; Strobl W; Kronenberg F
    Int J Obes (Lond); 2009 Oct; 33(10):1136-42. PubMed ID: 19636317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of apolipoprotein A gene polymorphisms on lipoprotein (a) concentrations in Japanese.
    Park HY; Nabika T; Notsu Y; Kobayashi S; Masuda J
    Clin Exp Pharmacol Physiol; 1999 Apr; 26(4):304-8. PubMed ID: 10225140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk.
    Nordestgaard BG; Tybjærg-Hansen A
    Curr Opin Lipidol; 2011 Apr; 22(2):113-22. PubMed ID: 21358543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein(a) polymorphism and plasma lipoprotein(a) levels.
    Pati U; Gambhir JK
    Indian Heart J; 2000; 52(2):171-2. PubMed ID: 10893892
    [No Abstract]   [Full Text] [Related]  

  • 18. High antifibrinolytic activity of lipoprotein(a) containing small apolipoprotein(a) isoforms.
    Anglés-Cano E
    Circulation; 2000 Dec; 102(25):E184-5. PubMed ID: 11120709
    [No Abstract]   [Full Text] [Related]  

  • 19. Lipoprotein (a) and apoliprotein (a) isoform size in thyroid disease: the quest for the golden fleece.
    Duntas LH
    Thyroid; 2003 Apr; 13(4):345-6. PubMed ID: 12812213
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lipoprotein (a) as a cardiovascular risk factor in man].
    Schneider R; Yagil Y
    Harefuah; 1997 Jan; 132(1):46-50. PubMed ID: 9035570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.